Visceral leishmaniasis in paediatrics

Current Opinion in Infectious Diseases

Volumn 15, Issue 3, 2002, Pages 289-294

  Kafetzis, Dimitris A ^a   Maltezou, Helen C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY DERIVATIVE; GAMMA INTERFERON; LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE; MILTEFOSINE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEVER; HEPATOSPLENOMEGALY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PANCYTOPENIA; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

EID: 0036107499     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200206000-00012     Document Type: Review

References (42)

1. Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approaches
2. Pediatric visceral leishmaniasis in Austria: Diagnostic difficulties in a non-endemic area
3. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study
4. Resistance to treatment in kala-azar: Speciation of isolates from northeast India
5. Leishmaniasis
6. Management of cutaneous leishmaniasis
7. Leishmaniasis in the Sudan: A literature review with emphasis on clinical aspects
8. Visceral leishmaniasis in children in the Yemen
9. Multi-site DNA polymorphism analyses of Leishmania isolates define their genotypes predicting clinical epidemiology of leishmaniasis in a specific region
10. Domestic and peridomestic transmission of American cutaneous leishmaniasis: Changing epidemiological patterns present new control opportunities
11. Visceral leishmaniasis in the metropolitan region of Belo Horizonte, State of Minas Gerais, Brazil
12. Visceral leishmaniasis during childhood in southern Greece
13. Visceral leishmaniasis in Malta: An 18 year paediatric, population based study
14. Visceral leishmaniasis: Also beware of these deceptive microbes in non-endemic countries
15. Visceral leishmaniasis in a German child who had never entered a known endemic area: Case report and review of the literature
16. Has leishmaniasis become endemic in the United States?
17. Leishmaniasis vaccination: Targeting the source of infection
18. Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis
19. Type 1/type 2 immunity in infectious diseases
20. Leishmaniasis: Current status of vaccine development
21. Genetic epidemiology of visceral leishmaniasis in northeastern Brazil
22. Childhood visceral leishmaniasis in Provence
23. Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children-a series of 12 cases
24. Post-kala-azar dermal leishmaniasis in the Sudan: Clinical presentation and differential diagnosis
25. Natural history of Leishmania chagasi infection in northeastern Brazil: Long-term follow-up
26. Malnutrition alters the innate response and increases early visceralization following Leishmania donovani infection
27. Leishmania donovani in blood smears of asymptomatic persons
28. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis
29. Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis
30. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: Experience from the Sudan
31. Human immune response to sand fly salivary gland antigens: A useful epidemiological marker?
32. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimonate
33. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic
34. Clinical and experimental advances in treatment of visceral leishmaniasis
35. Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent patients
36. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: Randomized trial
37. A single high dose treatment of kala-azar with AmBisome (amphotericin B lipid complex): A pilot study
38. Visceral leishmaniasis in India
39. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomised, double-blind, BCG-controlled trial in Sudan
40. Toward a defined anti-Leishmania vaccine targeting vector antigens: Characterization of a protective salivary protein
41. Factors associated with visceral leishmaniasis in Nepal: Bed-net use is strongly protective
42. Sand fly feeding on noxious plants: A potential method for the control of leishmaniasis